Army Drug Development Program. Phase 1. Clinical Testing.
Abstract
Results are presented for Phase I Clinical Studies: The Army Drug Development Program . Activities include Experiment 21, WR 2HC1: Short Term Safety and Tolerance Study and Experiment 22, The Effect of Low and High Caloric Diet upon the SGOT and SGPT of Normal Human Subjects. Keywords: Antimalarials, Leishmaniasis, WR 6026 2HC1, Hepatic enzymes, Abate, Diet, Human subjects, Serum glutamic oxaloacetic transaminase(SGOT), Serum glutamic pyruvic transaminase(SGPT).
Document Details
- Document Type
- Technical Report
- Publication Date
- Apr 01, 1985
- Accession Number
- ADA187423
Entities
People
- Richard C. Reba